We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.00 | 6.80 | 7.20 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 7.00 | 6.82 | 7.00 | 152,675 | 08:00:19 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.14M | -2.23M | -0.0233 | -3.00 | 6.68M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 04/12/2024 | 12:18 | ALNC |  Fusion Antibodies receives approval of grant funding application |
| 04/12/2024 | 11:31 | UK RNS | Fusion Antibodies PLC Approval of Grant Funding Application |
| 19/11/2024 | 13:10 | ALNC | Fusion Antibodies interim loss narrows as revenue more than doubles |
| 19/11/2024 | 07:00 | UK RNS | Fusion Antibodies PLC Half-year Report |
| 16/10/2024 | 12:23 | UK RNS | Fusion Antibodies PLC Director/PDMR Shareholding |
| 16/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC Issue of shares to non-executive directors |
| 08/10/2024 | 12:58 | ALNC | IN BRIEF: Fusion Antibodies expects interim revenue to double |
| 08/10/2024 | 11:32 | UK RNS | Fusion Antibodies PLC Result of AGM |
| 08/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC AGM statement and trading update |
| 02/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC Block admission six monthly return |
1 Year Fusion Antibodies Chart |
Intraday Fusion Antibodies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
